GPCL offers a cost-effective means to evaluate genetic issues in embryos including chromosome abnormalities, monogenic conditions and polygenic diseases. Our innovative methodology is entirely unique. We are the first lab to offer polygenic screening in embryos. GPCL represents the next step in preimplantation genetic testing, combining dense, genome-wide genotyping methods with sophisticated validation-focused modeling suitable for the information age.